Oral risk factors associated with medication-related osteonecrosis of the jaw in patients with cancer

被引：0
|
作者：
Nobuhiro Ueda
Kumiko Aoki
Hiroko Shimotsuji
Chie Nakashima
Mao Kawakami
Yuichiro Imai
Tadaaki Kirita
机构：
[1] Nara Medical University,Department of Oral and Maxillofacial Surgery
[2] Rakuwakai Otowa Hospital,Department of Oral and Maxillofacial Surgery
来源：
Journal of Bone and Mineral Metabolism | 2021年 / 39卷
关键词：
Bisphosphonate; Bone-modifying agent; Denosumab; Medication-related osteonecrosis of the jaw;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：623 / 630
页数：7
相关论文
共 50 条
  • [1] Oral risk factors associated with medication-related osteonecrosis of the jaw in patients with cancer
    Ueda, Nobuhiro
    Aoki, Kumiko
    Shimotsuji, Hiroko
    Nakashima, Chie
    Kawakami, Mao
    Imai, Yuichiro
    Kirita, Tadaaki
    JOURNAL OF BONE AND MINERAL METABOLISM, 2021, 39 (04) : 623 - 630
  • [2] Risk factors associated with prognosis of patients with medication-related osteonecrosis of the jaw
    Tadokoro, Yoshiaki
    Hasegawa, Takumi
    Takeda, Daisuke
    Murakami, Aki
    Yatagai, Nanae
    Arimoro, Satomi
    Iwata, Eiji
    Saito, Izumi
    Kusumoto, Junya
    Akashi, Masaya
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024, 46 (02): : 282 - 290
  • [3] The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors
    Dodson, Thomas B.
    ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA, 2015, 27 (04) : 509 - +
  • [4] Oral health management of patients at risk of medication-related osteonecrosis of the jaw
    不详
    British Dental Journal, 2017, 222 (12) : 930 - 930
  • [5] Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab
    Alexander Wick
    Philipp Bankosegger
    Sven Otto
    Bettina Hohlweg-Majert
    Timm Steiner
    Florian Probst
    Oliver Ristow
    Christoph Pautke
    Clinical Oral Investigations, 2022, 26 : 2839 - 2852
  • [6] Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab
    Wick, Alexander
    Bankosegger, Philipp
    Otto, Sven
    Hohlweg-Majert, Bettina
    Steiner, Timm
    Probst, Florian
    Ristow, Oliver
    Pautke, Christoph
    CLINICAL ORAL INVESTIGATIONS, 2022, 26 (03) : 2839 - 2852
  • [7] Risk factors of medication-related osteonecrosis of the jaw: A clinical investigation
    Komatsu, Yuko
    Kawai, Tadashi
    Hirano, Taifu
    Hoshi, Isao
    Yamaya, Genki
    Ogawa, Atsushi
    Chiba, Toshimi
    Yamada, Hiroyuki
    JOURNAL OF STOMATOLOGY ORAL AND MAXILLOFACIAL SURGERY, 2024, 125 (06)
  • [8] Risk factors for medication-related osteonecrosis of the jaw and salivary IL-6 IN cancer patients
    Tahara Kemp, Aristilia Pricila
    Candido Ferreira, Vitor Hugo
    Mobile, Rafael Zancan
    Brandao, Thais Bianca
    Sassi, Laurindo Moacir
    Zarpellon, Amanda
    Braz-Silva, Paulo Henrique
    Schussel, Juliana Lucena
    BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2022, 88 (05) : 683 - 690
  • [9] Prognostic factors of the medication-related osteonecrosis of the jaw
    Szentpeteri Szofia
    Restar Laszlo
    Nemeth Zsolt
    Vaszilko Mihaly
    ORVOSI HETILAP, 2020, 161 (08) : 283 - 289
  • [10] Medication-related osteonecrosis of the jaw associated with aflibercept
    Zarringhalam, P.
    Brizman, E.
    Shakib, K.
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2017, 55 (03): : 314 - 315
12345